Literature DB >> 3320232

Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

J Windeler1, J Köbberling.   

Abstract

Meta-analysis has been performed on the world literature relating to Haemoccult screening for colorectal cancer. The analysis indicated a sensitivity of about 50%, specificity of about 97%, positive predictive value of 4.3% and negative predictive value of 99.85%. These figures assume a prevalence of colorectal cancer in the population of 0.3%. A model calculation using these figures together with some additional realistic assumptions suggests no reduction in mortality compared to an unscreened population. It is concluded that many questions about faecal occult blood screening remain and that uncontrolled mass population screening is not justified at this stage.

Entities:  

Mesh:

Year:  1987        PMID: 3320232     DOI: 10.1007/BF01649510

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  66 in total

1.  [Occult blood in stool. A field trial in cancer screening (author's transl)].

Authors:  J Durst; G Neumann; K Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1976-03-19       Impact factor: 0.628

2.  Participation in mass screening for colorectal cancer with fecal occult blood test.

Authors:  K Klaaborg; M S Madsen; O Søndergaard; O Kronborg
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

3.  The Frome experiment--value of screening for colorectal cancer.

Authors:  P A Farrands; R L Griffiths; D C Britton
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

4.  The economics of screening for colo-rectal cancer.

Authors:  M M Kristein
Journal:  Soc Sci Med Med Econ       Date:  1980-12

5.  Debate over colon cancer screening.

Authors:  G Kolata
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

6.  A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.

Authors:  L Bat; A Pines; E Ron; Y Niv; E Arditi; E Shemesh
Journal:  Am J Gastroenterol       Date:  1986-08       Impact factor: 10.864

7.  Screening for colorectal cancer in a Hungarian county.

Authors:  L Ujszászy; G Prónay; G Nagy; J Kovács; J Libor; K Minik
Journal:  Endoscopy       Date:  1985-05       Impact factor: 10.093

8.  An immunologic test for fecal occult blood by counter immunoelectrophoresis. Higher sensitivity and higher positive reactions in colorectal cancer than single radial immunodiffusion and hemoccult test.

Authors:  H Saito; S Tsuchida; S Nakaji; R Kakizaki; T Aisawa; A Munakata; Y Yoshida
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

9.  A screening primer: basic principles, criteria, and pitfalls of screening with comments on colorectal carcinoma.

Authors:  J J Chuong
Journal:  J Clin Gastroenterol       Date:  1983-06       Impact factor: 3.062

10.  A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.

Authors:  N Armitage; J D Hardcastle; S S Amar; T W Balfour; J Haynes; P D James
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

View more
  1 in total

1.  Is there a preference for different ways of performing faecal occult blood tests?

Authors:  J D Kettner; C Whatrup; J E Verne; K Young; C B Williams; J M Northover
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.